Upstate Active Clinical Trials

Study Title:

A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients with Early Alzheimer’s Disease (BenfoTeam)

What is the purpose of the study? (in Layman's terms, please describe the study)

To see if a lab made version of Vitamin B1 (benfotiamine) can be used to prevent or improve symptoms of memory loss in individuals with Mild Cognitive Impairment or Mild Alzheimer's Dementia.

Upstate Institutional Review Board (IRB) Number:

2018455

Study/Protocol ID:

ADC-061-BENFO

Study Phase:

Phase 2A/2B

Patient Age Group:

Adults

Principal Investigator:

Sharon A Brangman

What is involved if I participate?

• How long is the study?
  18 months
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  Yes
• What tests and procedures are involved?
  Memory testing, MRI, blood draws, EKG, questionnaires

Where will the study take place?

Clinical Research Unit (CRU)

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT06223360

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Kevin Hanretty, MS
Phone: 315-464-8373
Email: [email protected]

Return to Previous Page || Search Again